- Home
- DSGN vs GHG Comparison
DSGN vs GHG Comparison
Compare DSGN & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- GHG
- Stock Information
- Founded
- DSGN 2017
- GHG 2004
- Country
- DSGN United States
- GHG China
- Employees
- DSGN N/A
- GHG N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- DSGN Health Care
- GHG Consumer Discretionary
- Exchange
- DSGN Nasdaq
- GHG Nasdaq
- Market Cap
- DSGN 208.9M
- GHG 202.0M
- IPO Year
- DSGN 2021
- GHG 2018
- Fundamental
- Price
- DSGN $3.77
- GHG $2.18
- Analyst Decision
- DSGN Hold
- GHG
- Analyst Count
- DSGN 1
- GHG 0
- Target Price
- DSGN $4.00
- GHG N/A
- AVG Volume (30 Days)
- DSGN 82.2K
- GHG 12.5K
- Earning Date
- DSGN 08-04-2025
- GHG 08-14-2025
- Dividend Yield
- DSGN N/A
- GHG 4.58%
- EPS Growth
- DSGN N/A
- GHG N/A
- EPS
- DSGN N/A
- GHG 0.15
- Revenue
- DSGN N/A
- GHG $184,055,595.00
- Revenue This Year
- DSGN N/A
- GHG $19.02
- Revenue Next Year
- DSGN N/A
- GHG $8.26
- P/E Ratio
- DSGN N/A
- GHG $14.71
- Revenue Growth
- DSGN N/A
- GHG N/A
- 52 Week Low
- DSGN $2.60
- GHG $1.93
- 52 Week High
- DSGN $7.77
- GHG $3.40
- Technical
- Relative Strength Index (RSI)
- DSGN 49.66
- GHG 62.74
- Support Level
- DSGN $3.33
- GHG $1.97
- Resistance Level
- DSGN $4.21
- GHG $2.46
- Average True Range (ATR)
- DSGN 0.24
- GHG 0.11
- MACD
- DSGN -0.02
- GHG 0.04
- Stochastic Oscillator
- DSGN 50.29
- GHG 74.53
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.